CTSO CytoSorbents Corporation: Operating Margin

Corporate emblem and logo of CytoSorbents Corp (CTSO)

Cytosorbents minimizes risks by developing blood purification systems for intensive care units. The current operating margin illustrates this efficiency, where -26.70 characterizes this valuation parameter. Profit stability is based on a global distribution network across Europe and the US. The defensive qualities of the business and demographic factors insulate financial results from market downturns.

CTSO: CytoSorbents Corp. Operating Margin 07/04/2022 - 11/19/2026

CytoSorbents Corp - analytical breakdowns and key metrics (CTSO)

- share price and consensus valuation forecast:
Fundamental company analysis:CTSO, CytoSorbents Corporation
Brand item of CytoSorbents Corporation

The effective commercialization of blood filtration systems in the US and EU directly correlates with the operating profit spread, calculated as the ratio of operating profit to revenue. This chart allows for an assessment of Cytosorbents (CTSO) management's ability to transform revenues into net operating cash flow before financial obligations, confirming the stability of the market capitalization through the fundamental efficiency of the business model.

Competitors of Cytosorbents (CTSO)

DXCM (Dexcom CGM) - Operating Margin|Operating Sales Margin Penumbra Corp (PEN)|Operating Margin NOVT|Operating Margin haemonetics.com (HAE)|Operating Margin INSP (inspiresleep.com)|Operating Margin PROCEPT BioRobotics Corp PRCT|CNMD - Operating Profitability|PLSE: Operating Profitability|INMD (InMode Ltd.) - Operating Sales Margin|Operating Return on Sales picardmedical.com (PMI)|SRDX (Surmodics Inc.) - Operating Margin|Operating Return on Sales Senseonics SENS|Operating Profitability NeuroPace Inc (NPCE)|Tactile Systems Technology Inc. (TCMD) - Operating Profitability Margin|SANUWAVE Health Inc - Operating Sales Margin|OM (outsetmedical.com) - Operating Profit Margin|SmartVest - Operating Margin|Profitability of Operations LENSAR Inc. LNSR|AVITA Medical (RCEL) - Operating Profitability|Operating Profit Margin PROF (Profound Medical Corporation)|Operating Profitability bairdmed.com|Operating Sales Margin EDAP TMS S.A. (EDAP)|Operating Margin APYX|ICCM - Operating Return on Sales|Operating Profitability pulmonx.com LUNG|TELA: Return on Sales by Operating Profit|SRTS: Operating Sales Margin|Zynex - Operating Profit Ratio|ECOR: Operating Margin|RBOT (Vicarious Surgical Inc) - Operating Profitability|Operating Profitability Inspira Technologies|Operating Margin SeaStar Medical Holding Corp.|Operating Margin IRIX|Operating Profit Ratio INBS|Operating Profitability Beyond Air XAIR|PFSA (Profusa, Inc.) - Operating Profit Margin|SSKN: Operating Sales Margin|Operating Return on Sales GlucoTrack|NAOV: Operating Margin|Venus Concept Inc. - Operating Profit Rate|NUWE (Nuwellis Inc) - Operating Margin|Return on Sales by Operating Profit AEMD (Aethlon)|Operating Sales Margin ASXC (Asensus Surgical Inc)|AVGR (Avinger, Inc) - Operating Profit Rate|Operating Margin BSGM (BioSig Technologies, Inc.)|CUTR: Return on Sales by Operating Profit|Know Labs Inc - Operating Margin|Profitability of Operations Inari Medical NARI|NVRO (Nevro Medical) - Operating Sales Margin|Operating Profit Margin RSLS (ReShape Lifesciences, Inc.)|SILK (Silk Road Medical, Inc.) - Operating Margin